Diabetes Cholesterol Comprehensive Profile Panel
This blood test panel combines A1c, glucose/insulin markers, and a full lipid profile to track diabetes control and cardiovascular risk together.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a bundled lab panel, not a single test. It pulls together key diabetes markers (short- and longer-term glucose control) plus a comprehensive cholesterol/lipid profile, so you can see how blood sugar management and cardiovascular risk markers are moving at the same time—especially useful if you are adjusting lifestyle, starting or titrating medications (including GLP-1 therapy), or trying to make sense of mixed signals like “my A1c improved but my fasting glucose didn’t.”
Do I need this panel?
You may want the Diabetes Cholesterol Comprehensive Profile panel if you are tracking prediabetes or type 2 diabetes and you also care about your lipid numbers (LDL, HDL, triglycerides) because cardiometabolic risk is a combined story. This panel is designed for those moments when you do not want to guess which single test to order—you want a coordinated snapshot.
This panel can be a good fit if your day-to-day glucose readings and your A1c do not seem to match, if you are seeing a weight-loss plateau and want objective feedback, or if you are monitoring medication changes (for example, starting or adjusting GLP-1 therapy, metformin, or a statin). It is also useful when you are trying to protect lean mass and metabolic health during weight loss—because improving glucose control while worsening triglycerides (or vice versa) can change what “success” looks like.
If you already have a diabetes diagnosis, this panel can help you and your clinician check whether your current plan is controlling glucose over weeks to months and whether your lipid pattern suggests higher or lower cardiovascular risk. If you are newly diagnosed or in the “borderline” range, it can help confirm where you are on the spectrum and what to prioritize next.
This panel supports clinician-directed care and shared decision-making; it is not meant for self-diagnosis or changing prescriptions on your own.
Results and reference ranges can vary by lab and method; interpret patterns across the panel (not one number in isolation) and trend results over time when possible.
Lab testing
Order the Diabetes Cholesterol Comprehensive Profile panel
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order a cardiometabolic lab panel when you want more than a single marker. You can use this panel to establish a baseline, check progress after a change in nutrition, activity, or medication, or confirm whether improvements in glucose control are happening alongside (or at the expense of) your lipid profile.
After your blood draw, you will have a set of results that are meant to be read together: longer-term glucose exposure (A1c), current glucose status, insulin-related context, and a detailed lipid breakdown. If you want help turning that set of numbers into an action plan and follow-up questions for your clinician, PocketMD can help you interpret the pattern in plain language.
This panel is also useful for retesting. Many people benefit from repeating the same panel after a consistent interval (often weeks to a few months, depending on what changed) so you can see directionality rather than reacting to one-off variability.
If you are focusing specifically on glucose-insulin pairing, you may also consider a more targeted glucose/insulin-focused panel as a follow-up or add-on, depending on your goals.
- Order a single bundled panel instead of piecing together separate tests
- Designed to interpret glucose control and lipid risk side-by-side
- PocketMD can help you summarize patterns and prepare questions for your clinician
- Retesting-friendly: compare trends after lifestyle or medication changes
Key benefits of the Diabetes Cholesterol Comprehensive Profile panel
- Checks both longer-term glucose exposure (A1c) and current glucose status in the same panel.
- Adds insulin-related context so you can better understand insulin resistance patterns behind glucose numbers.
- Pairs diabetes markers with a comprehensive lipid profile to assess cardiometabolic risk together.
- Helps explain common “mismatch” situations, like improved A1c with stubborn fasting glucose (or the reverse).
- Supports medication monitoring conversations, including GLP-1 therapy, metformin, and lipid-lowering treatment.
- Creates a clean baseline for trend tracking after weight loss, training changes, or nutrition adjustments.
- Reduces guesswork by bundling the most commonly co-interpreted diabetes and cholesterol labs in one draw.
What is the Diabetes Cholesterol Comprehensive Profile panel?
The Diabetes Cholesterol Comprehensive Profile is a multi-biomarker blood test panel that combines core diabetes monitoring labs with a detailed cholesterol/lipid assessment. Instead of ordering separate tests at different times, you get a coordinated set of results that reflect (1) how much glucose your body has been exposed to over the last several weeks to months, (2) what your glucose and insulin look like right now, and (3) how your blood lipids are trending—an important part of cardiovascular risk.
A key reason to run these together is that glucose control and lipid metabolism are tightly linked. Insulin resistance can raise triglycerides, lower HDL cholesterol, and shift LDL particles in ways that matter even when “total cholesterol” looks fine. Likewise, changes in diet, weight, and medications can improve one area while temporarily worsening another. A bundled panel helps you see the tradeoffs and the overall direction.
This panel is commonly used by people tracking prediabetes, type 2 diabetes, metabolic syndrome, or cardiometabolic risk—especially when you are changing something meaningful (for example, starting a GLP-1 medication, increasing protein and resistance training, changing carbohydrate intake, or beginning a statin).
What the diabetes side of the panel tells you
The diabetes portion typically includes hemoglobin A1c (HbA1c), which reflects average glucose exposure over roughly 2–3 months, plus a fasting glucose measurement that reflects your blood sugar at that moment. When fasting insulin is included, it adds context about how hard your pancreas is working to keep glucose controlled. Together, these results can hint at insulin resistance, early dysglycemia, or whether your current plan is effectively lowering glucose exposure over time.
What the cholesterol/lipid side of the panel tells you
A comprehensive lipid profile goes beyond a single cholesterol number. It usually includes total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and calculated values such as non-HDL cholesterol and cholesterol ratios. These markers help you and your clinician estimate cardiovascular risk and decide whether lifestyle changes, medication, or further testing is appropriate—especially in the context of diabetes, where lipid patterns can carry additional risk.
Why the combination matters (especially during weight loss or medication changes)
During weight loss—whether from lifestyle changes or GLP-1 therapy—your glucose markers may improve quickly, while lipids can change in more complex ways depending on diet composition, energy balance, and genetics. Some people see triglycerides drop and HDL rise; others see LDL rise transiently during rapid fat loss. Looking at glucose and lipids together helps you avoid overreacting to a single marker and instead focus on the overall cardiometabolic trajectory.
What do my panel results mean?
When key parts of the panel are low
“Low” in this panel usually means low glucose exposure and/or low lipid levels, and the interpretation depends on which markers are low. Lower A1c and fasting glucose are generally reassuring if they match how you feel and you are not having hypoglycemia symptoms. Very low fasting glucose (especially with symptoms like shakiness, sweating, confusion, or palpitations) deserves prompt clinical attention, particularly if you use glucose-lowering medications. On the lipid side, low triglycerides and higher HDL are often favorable, but unusually low total cholesterol or LDL can occur with certain medications, undernutrition, malabsorption, hyperthyroidism, or other medical conditions—so it is best interpreted in context rather than assumed to be “better” automatically.
When the panel looks optimal and consistent
An “optimal” pattern is one where your longer-term marker (A1c) and your current marker (fasting glucose) tell a consistent story, and your lipid profile supports lower cardiometabolic risk. In practice, that often looks like A1c and fasting glucose that align with your goals, fasting insulin that is not disproportionately high for your glucose level, and a lipid pattern with lower triglycerides, adequate HDL, and LDL/non-HDL values that fit your personal risk profile. The most useful signal is often stability and direction over time—seeing glucose control improve without a worsening lipid pattern (or seeing both improve together) is typically the clearest sign your plan is working.
When key parts of the panel are high
High results can show up on the glucose side, the lipid side, or both—and the combination matters. A higher A1c suggests higher average glucose exposure over the prior weeks to months; if fasting glucose is also high, that supports persistent hyperglycemia rather than isolated spikes. If A1c is high but fasting glucose is closer to normal, it can point to post-meal spikes, variability, or factors that affect A1c interpretation. On the lipid side, high triglycerides and low HDL commonly travel with insulin resistance, while higher LDL or non-HDL cholesterol may increase cardiovascular risk depending on your overall profile. If both glucose markers and atherogenic lipids are elevated, that pattern usually supports a more proactive discussion with your clinician about therapy intensity, lifestyle strategy, and whether additional risk markers are needed.
Factors that influence your panel results
Several real-world factors can shift this panel without reflecting a permanent change in your health. Recent illness, poor sleep, acute stress, and changes in training volume can raise glucose and sometimes triglycerides. Fasting duration and alcohol intake in the days before testing can meaningfully affect triglycerides and glucose. Medications matter: GLP-1 therapy can improve glucose and often triglycerides, while statins can lower LDL but may slightly raise glucose in some people; steroids and some psychiatric medications can raise glucose and lipids. A1c can be misleading in conditions that change red blood cell turnover (for example, certain anemias or recent blood loss), and lipids can shift during rapid weight loss or major dietary changes. Because this is a multi-marker panel, the most reliable interpretation comes from looking for consistent patterns across markers and trending the same panel over time.
What’s included in this panel
- 1,5 Ag, Intermediate Glycemic Control
- Absolute Band Neutrophils
- Absolute Basophils
- Absolute Blasts
- Absolute Eosinophils
- Absolute Lymphocytes
- Absolute Metamyelocytes
- Absolute Monocytes
- Absolute Myelocytes
- Absolute Neutrophils
- Absolute Nucleated Rbc
- Absolute Plasma Cells
- Absolute Prolymphocytes
- Absolute Promyelocytes
- Absolute Reactive Lymphocytes
- Albumin
- Albumin/Creatinine Ratio, Random Urine
- Albumin/Globulin Ratio
- Albumin, Urine
- Alkaline Phosphatase
- Alt
- Amorphous Sediment
- Apolipoprotein A1
- Apolipoprotein B
- Apolipoprotein B/A1 Ratio
- Appearance
- Ast
- Bacteria
- Band Neutrophils
- Basophils
- Bilirubin
- Bilirubin, Total
- Blasts
- Bun/Creatinine Ratio
- C-Peptide
- Calcium
- Calcium Oxalate Crystals
- Carbon Dioxide
- Casts
- Chloride
- Chol/Hdlc Ratio
- Cholesterol, Total
- Color
- Cortisol, Total
- Creatinine
- Creatinine, Random Urine
- Crystals
- Egfr
- Eosinophils
- Fibrinogen Activity, Clauss
- Free T4 Index (T7)
- Globulin
- Glucose
- Granular Cast
- Hdl Cholesterol
- Hematocrit
- Hemoglobin
- Hemoglobin A1C
- Hs Crp
- Hyaline Cast
- Insulin
- Ketones
- Ldl-Cholesterol
- Leukocyte Esterase
- Lipoprotein (A)
- Lymphocytes
- Mch
- Mchc
- Mcv
- Metamyelocytes
- Monocytes
- Mpv
- Myelocytes
- Neutrophils
- Nitrite
- Non Hdl Cholesterol
- Nucleated Rbc
- Occult Blood
- Ph
- Plasma Cells
- Platelet Count
- Potassium
- Prolymphocytes
- Promyelocytes
- Protein
- Protein, Total
- Rbc
- Rdw
- Reactive Lymphocytes
- Red Blood Cell Count
- Renal Epithelial Cells
- Sodium
- Specific Gravity
- Squamous Epithelial Cells
- T3, Free
- T3, Reverse, Lc/Ms/Ms
- T3, Total
- T4, Free
- T4 (Thyroxine), Total
- Thyroglobulin Antibodies
- Thyroid Peroxidase Antibodies
- Transitional Epithelial Cells
- Triglycerides
- Triple Phosphate Crystals
- Tsh
- Urea Nitrogen (Bun)
- Uric Acid Crystals
- Wbc
- White Blood Cell Count
- Yeast
Frequently Asked Questions
Do I need to fast for this panel?
Fasting is commonly recommended because triglycerides and fasting glucose/insulin are easiest to interpret when you have not eaten recently. If your draw is non-fasting, you can still learn a lot, but triglycerides and insulin in particular may be harder to compare to prior results. Follow the instructions provided with your order, and keep your pre-test routine consistent when you retest.
How often should I repeat this panel?
It depends on what you are changing and what decisions you are trying to make. A1c reflects roughly 2–3 months of glucose exposure, so repeating too soon may not show the full effect. Many people retest after a consistent interval (often 8–12 weeks) following a medication change or a sustained lifestyle shift, then less frequently once stable. Your clinician may recommend a different cadence based on your risk and treatment plan.
Why can my A1c improve while my fasting glucose stays high (or the opposite)?
A1c is an average over time, while fasting glucose is a single moment. You can have improved overall averages with persistent morning elevations (sometimes related to overnight hormone patterns, sleep, or medication timing). You can also have a fasting glucose that looks okay while post-meal spikes push A1c higher. Conditions that affect red blood cell turnover can also make A1c read higher or lower than expected. Looking at the full panel together helps you decide what to investigate next.
If I’m on a GLP-1 medication, what should I pay attention to in this panel?
This panel helps you track whether glucose exposure is improving (A1c and fasting glucose) and whether your lipid pattern is moving in a favorable direction as weight and appetite change. If your glucose markers improve but you feel unwell, have symptoms of low blood sugar, or your fasting glucose becomes unusually low, you should contact your clinician promptly. If LDL rises during rapid weight loss, it may be temporary, but it is still worth discussing in the context of your overall risk and family history.
Is this panel the same as a standard lipid panel plus A1c?
It overlaps with those tests, but the value is in the bundled, co-interpreted view—especially when fasting insulin and calculated lipid metrics (like non-HDL cholesterol and ratios) are included. A standard lipid panel alone does not tell you how glucose control is trending, and A1c alone does not show whether your lipid risk markers are improving or worsening alongside glucose changes.
Should I order this panel or order tests separately?
If your goal is to understand cardiometabolic risk as a whole, a bundled panel is usually simpler and easier to trend because the markers are drawn together and interpreted as a set. Ordering separately can make sense if you only need one follow-up marker (for example, rechecking A1c alone) or if your clinician is targeting a specific question. Many people use the comprehensive panel for baseline and periodic check-ins, then use narrower panels for in-between monitoring.